ARKK vs ARQT
ARK Innovation ETF (ARKK) versus Arcutis Biotherapeutics Inc (ARQT) — a side-by-side from cached financials, not a winner call.
ARK Innovation ETF (ARKK) common stock listed on US.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
ARKK does not have a complete income-statement cache yet.
Latest reported ARQT revenue for 2026-06-30 was $235.3M. Net income was $3.7M. ARQT currently screens at market cap $1.64B.
ARKK currently screens at market cap $0. ARQT currently screens at market cap $1.64B.
Not investment advice. Open the ARKK and ARQT stock pages for the full models.
Not investment advice.